PulmoTrack An Innovative New System for Wheeze Identification & Quantification

Asthma is reversible airflow obstruction, associated with a state of increased responsiveness of the tracheobronchial tree to many different stimuli (that do not affect normal individuals).
…Patients experience dyspnea, cough and wheezing as the major complaints.

Tintinalli: Emergency Medicine, American College of Emergency Physicians


PulmoTrack® enables the continuous monitoring of wheeze and cough*.
This easy, quick and noninvasive system provides:

  • Wheeze by wheeze identification
  • Accurate measurement of Wheeze Rate
  • Classification of wheeze as inspiratory or expiratory
  • Respiratory rate and I\E ratio
  • Cough* Counting

WHEEZE RATE: Proportion of the respiratory cycle duration occupied by wheezing – Tw/Ttot

Respiratory Acoustic Monitor

The PulmoTrack® Respiratory Acoustic Monitor can be used for:

  • Bronchodilatation Test: Measurement of
    response to treatment.
  • Bronchoprovocation Test particularly for
    infants or other non-cooperative patients.
  • Performance of physical examination in a pulmonary function testing environment to identify and quantify the presence of wheezing.

The PulmoTrack® Respiratory Acoustic Monitor system consists of two acoustic sensors attached to the skin over the trachea and chest with disposable acoustic insulating adhesive pads, a pneumo graph belt sensor for documenting breathing activity, and an ambient microphone to filter environmental noises.

Wheeze detection is carried out by patented* software using advanced algorithms that apply strict criteria to determine the presence of wheezing, as defined by CORSA (Computerized Respiratory Sound Analysis) guidelines1.

1. Sovijärvi ARA, Dalmasso F, Vanderschoot J, Malmberg LP, Righini G, Stoneman SAT, Definition of terms for application of respiratory sounds.Eur Respir Rev 2000;10:597-610

PulmoTrack® facilitates improved patient management.

  • Minimum patient active effort offers previously unavailable objective pulmonary symptoms documentation in all age groups and continuous overnight monitoring.
  • Precise measurement of wheeze rate provides quantitative patient data.
  • Archivable and retrievable reports over a period of time enable the following of symptom trends.
  • Detailed graphical spectral display and acoustic playback features allow review of specific records for secondary data analysis.

 

PulmoTrack® Specifications

System Components 2-ppg™ Sensors
Respiratory Sensor including belt
Signal conditioning unit
Analog/digital converting unit
Laptop computer
Acoustic adhesive pads
System case
Sensors Piezoelectric, useful range – 75-4000Hz
Adhesive Pads Biocompatible, noise shield
Software KarmelSonix dedicated software
Software Features Data analysis – wheeze detection
Wheeze rate %
Respiratory rate
I:E Ratio
Data archiving & retrieval
Zooming
Audio playback
Printable reports
*PulmoTrack™ is protected by patent numbers: US 6,168,568, US 6,261,238 & EP 0944355. PulmoTrack™ is FDA, CE & TGA cleared.